---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-040599"
form_type: "8-K"
ticker: "AIXC"
cik: "0001460702"
company_name: "AIxCrypto Holdings, Inc."
filed_at: "2024-10-09T23:59:59+00:00"
generated_at: "2026-05-30T17:13:23.118507+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Qualigen Therapeutics adds Braeden Lichti to board; Robert Lim named audit chair; Korenberg resigns

## Summary
- Matt Korenberg resigned director and audit chair Oct 3, 2024; no disagreement cited.
- Braeden Lichti appointed independent director Oct 8, 2024; founder of BWL Investments and NorthStrive.
- Robert Lim appointed as audit committee chairperson effective Oct 8, 2024.
- Director agreement includes $5,000 monthly base fee, equity eligibility, and standard indemnification.

## SEC filing metadata
- accession: 0001493152-24-040599
- form_type: 8-K
- ticker: AIXC
- cik: 0001460702
- company_name: AIxCrypto Holdings, Inc.
- filed_at: 2024-10-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1460702/000149315224040599/0001493152-24-040599-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1460702/000149315224040599/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-040599
- JSON: https://secwatch.observer/filing/0001493152-24-040599.json
- Plain text: https://secwatch.observer/filing/0001493152-24-040599.txt

## Key facts
- Executive change
  Braeden Lichti was appointed as Independent Director at AIxCrypto Holdings, Inc..
  - Action: appointed
  - Role: Independent Director
  source text: On October 8, 2024, the Board of Directors (the “Board”) appointed Braeden Lichti as an independent member of the Board, effective immediately, and approved the Director Agreement, attached hereto as Exhibit 10.1.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1460702/000149315224040599/0001493152-24-040599-index.htm
- Executive change
  Matt Korenberg resigned as Independent Director and Chairman of Audit Committee at AIxCrypto Holdings, Inc..
  - Action: resigned
  - Role: Independent Director and Chairman of Audit Committee
  source text: On October 3, 2024, Mr. Matt Korenberg, independent member and chairman of the audit committee of the board of directors (the “Board”) of Qualigen Therapeutics, Inc. (the “Company”), tendered his resignation from all positions held with the Company, with such resignation becoming effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1460702/000149315224040599/0001493152-24-040599-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.